Flexible Dosing Medications to Help Your Pharmacy Thrive

Independent pharmacies are under immense pressure. Reimbursements are falling, audits are increasing, and pharmacy benefit managers (PBMs) continue to squeeze margins. Many pharmacies are stuck filling high volumes of low-margin prescriptions just to stay afloat, all while trying to deliver quality care to their communities.

Real Value RX offers a smarter path forward. Instead of chasing volume, their program helps pharmacies increase profitability through intentional changes like dispensing FDA-approved, underutilized formulations that improve both patient outcomes and financial performance. These products are often excluded from MAC lists, offer better reimbursement, and are supported by co-pay assistance.

This isn’t about making a quick buck. It’s a long-term strategy grounded in compliance, sustainability, and smarter business practices. Real Value RX also ensures DSCSA compliance and minimal disruption to PVA rebate structures. By identifying just a few high-impact prescriptions, pharmacies can reduce stress, improve care, and build a more stable future without overhauling their entire operation.

In a session titled “Flexible Dosing Medications to Help Your Pharmacy Thrive” presented at the Total Pharmacy Solutions Summit Summer 2025 event, Stephanie Zimmerman, director of business development at Real Value RX, Tom Napolitano, senior vice president and general manager at Real Value RX, and Luke Gunderson, director of sales at Real Value RX, discussed how Real Value RX is helping thousands of pharmacies grow by offering over 5,000 generics plus unique, flexible formulations that drive clinical impact and meaningful financial returns.

“Everything we offer is designed to support the independent pharmacist because we know the value you bring to your community and health care as a whole,” Gunderson said. “We're proud to sell these products because we know the good you do, and we want to give you tools to survive, thrive, and help more patients.”

Explore more of our coverage from the Total Pharmacy Solutions Summit Summer 2025: Revenue Stream Diversification.

Summer 2025: Smarter Revenue Strategies for Independent Pharmacies